Chimerix Inc (CMRX)
1.02
+0.05
(+5.09%)
USD |
NASDAQ |
May 09, 16:00
1.01
-0.01
(-0.98%)
After-Hours: 06:47
Chimerix Cash from Financing (TTM): 0.317M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 0.317M |
December 31, 2023 | 0.308M |
September 30, 2023 | 0.214M |
June 30, 2023 | 0.914M |
March 31, 2023 | 0.934M |
December 31, 2022 | -12.72M |
September 30, 2022 | -12.64M |
June 30, 2022 | -12.86M |
March 31, 2022 | -12.73M |
December 31, 2021 | 112.43M |
September 30, 2021 | 112.72M |
June 30, 2021 | 112.43M |
March 31, 2021 | 112.89M |
December 31, 2020 | 1.413M |
September 30, 2020 | 1.068M |
June 30, 2020 | 0.974M |
March 31, 2020 | 0.414M |
December 31, 2019 | 0.345M |
September 30, 2019 | 0.714M |
June 30, 2019 | 11.17M |
March 31, 2019 | 11.21M |
December 31, 2018 | 11.19M |
September 30, 2018 | 10.76M |
Date | Value |
---|---|
June 30, 2018 | 0.475M |
March 31, 2018 | 0.522M |
December 31, 2017 | 0.779M |
September 30, 2017 | 0.849M |
June 30, 2017 | 0.92M |
March 31, 2017 | 0.837M |
December 31, 2016 | 0.608M |
September 30, 2016 | 0.081M |
June 30, 2016 | -0.336M |
March 31, 2016 | 160.81M |
December 31, 2015 | 161.35M |
September 30, 2015 | 276.97M |
June 30, 2015 | 277.13M |
March 31, 2015 | 226.66M |
December 31, 2014 | 225.26M |
September 30, 2014 | 110.09M |
June 30, 2014 | 109.05M |
March 31, 2014 | 106.13M |
December 31, 2013 | 106.17M |
September 30, 2013 | 106.23M |
June 30, 2013 | 119.08M |
March 31, 2013 | 11.29M |
December 31, 2012 | 12.31M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-12.86M
Minimum
Jun 2022
112.89M
Maximum
Mar 2021
20.91M
Average
0.814M
Median
Cash from Financing (TTM) Benchmarks
UFP Technologies Inc | -30.02M |
Dentsply Sirona Inc | -338.00M |
Arbutus Biopharma Corp | 34.66M |
Pacira BioSciences Inc | -31.94M |
Karyopharm Therapeutics Inc | 1.124M |